Stay updated on Relatlimab and Ipilimumab in Advanced Melanoma Clinical Trial

Sign up to get notified when there's something new on the Relatlimab and Ipilimumab in Advanced Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Relatlimab and Ipilimumab in Advanced Melanoma Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The revision history now shows a new version entry (v3.4.3) and removes the previous entry (v3.4.2). This is a metadata update to the page's version history.
    Difference
    0.1%
    Check dated 2026-03-11T17:09:36.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added and prior notices about government funding and operating status (v3.4.1) were removed.
    Difference
    0.5%
    Check dated 2026-02-11T01:53:51.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Added a site-wide notice about potential delays due to a lapse in government funding and updated the page revision from v3.4.0 to v3.4.1. This does not affect study data or core content on the history page.
    Difference
    0.5%
    Check dated 2026-02-03T23:00:36.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    The Record History page now includes a glossary toggle and color-coded highlights for additions and deletions. The revision note updated from v3.3.4 to v3.4.0 to reflect the new version.
    Difference
    0.7%
    Check dated 2026-01-27T21:12:48.000Z thumbnail image
  7. Check
    56 days ago
    Change Detected
    Summary
    The revision label at the bottom updated from v3.3.3 to v3.3.4.
    Difference
    0.1%
    Check dated 2026-01-20T15:36:08.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    Footer now shows Revision: v3.3.3 and the HHS Vulnerability Disclosure link has been removed; the rest of the page content and structure remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-22T22:22:40.000Z thumbnail image

Stay in the know with updates to Relatlimab and Ipilimumab in Advanced Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Relatlimab and Ipilimumab in Advanced Melanoma Clinical Trial page.